These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9533646)
1. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin. Bhargava HN; Cao YJ Peptides; 1998; 19(3):563-8. PubMed ID: 9533646 [TBL] [Abstract][Full Text] [Related]
2. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. Bhargava HN; Cao YJ; Zhao GM Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462 [TBL] [Abstract][Full Text] [Related]
3. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice. Bhargava HN; Cao YJ; Zhao GM Peptides; 1997; 18(6):797-800. PubMed ID: 9285927 [TBL] [Abstract][Full Text] [Related]
4. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. Cao YJ; Bhargava HN Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909 [TBL] [Abstract][Full Text] [Related]
6. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice. Bian JT; Bhargava HN Peptides; 1996; 17(8):1415-9. PubMed ID: 8971939 [TBL] [Abstract][Full Text] [Related]
7. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse. Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse. Bhargava HN; Cao YJ Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726 [TBL] [Abstract][Full Text] [Related]
9. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
10. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
11. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632 [TBL] [Abstract][Full Text] [Related]
12. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat. Harada Y; Nishioka K; Kitahata LM; Nakatani K; Collins JG Anesthesiology; 1995 Aug; 83(2):336-43. PubMed ID: 7631956 [TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse. Xu JY; Tseng LF Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior. Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637 [TBL] [Abstract][Full Text] [Related]
15. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076 [TBL] [Abstract][Full Text] [Related]
16. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350 [TBL] [Abstract][Full Text] [Related]
17. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171 [TBL] [Abstract][Full Text] [Related]
18. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat. Danzebrink RM; Green SA; Gebhart GF Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489 [TBL] [Abstract][Full Text] [Related]
19. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. Kest B; McLemore G; Kao B; Inturrisi CE J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000 [TBL] [Abstract][Full Text] [Related]
20. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]